Status:
UNKNOWN
Genotype and Susceptibility to COVID-19
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is a viral disease induced by infection with the novel SARS-CoV-2 coronavirus. Infection arises from the inhalation of viral particles spread by an infected individual. The main virus entry p...
Eligibility Criteria
Inclusion
- \- Age \> 18 years
Exclusion
- None
Key Trial Info
Start Date :
November 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04799834
Start Date
November 30 2020
End Date
June 1 2024
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"
Ranica, BG, Italy, 24020